Journal Information
Vol. 1. Issue 1.
Pages 52-55 (May - June 2005)
Share
Share
Download PDF
More article options
Vol. 1. Issue 1.
Pages 52-55 (May - June 2005)
Caso clínico
Full text access
Vasculitis asociadas a ANCA en artritis reumatoide. Descripción de un caso de poliangeitis microscópica y otro de enfermedad de Wegener
Vasculitis associated with anti-neutrophil cytoplasmic autoantibodies in rheumatoid arthritis. Report of a case of microscopic polyangiitis and another case of Wegener’s granulomatosis
Visits
41555
A. Ruiz-Zorrilla, M. Picazo, I. González-Álvaro, R. Gómez-Gil, R. García de Vicuña
Corresponding author
vicuna1@mi.madritel.es

Correspondencia: Dra. R. García de Vicuña. Servicio de Reumatología. Hospital Universitario de la Princesa. UAM. Diego de León, 62. 28006 Madrid. España.
Servicio de Reumatología. Hospital Universitario de la Princesa. UAM. Madrid. España
This item has received
Article information

La vasculitis es una complicación infrecuente de la arthritis reumatoide que se asocia con un aumento claro de la morbimortalidad, aunque son muy raras las manifestaciones sistémicas como glomerulonefritis, vasculitis cerebral o vasculitis pulmonar. A su vez, las vasculitis sistémicas con afectación renal se asocian en menos del 5% a poliartritis franca y la asociación con artritis reumatoide es excepcional. La determinación de los anticuerpos anticitoplasma de neutrófilo (ANCA), utilizados en el contexto clínico apropiado, se ha convertido en una importante herramienta diagnóstica de las vasculitis sistémicas de pequeño vaso. Presentamos 2 pacientes diagnosticados de artritis reumatoide que posteriormente desarrollaron vasculitis sistémica, en los que la determinación de ANCA fue decisiva en el diagnóstico precoz.

Palabras clave:
Artritis reumatoide
Vasculitis
ANCA

Vasculitis is an uncommon complication of rheumatoid arthritis that is associated with a clear increase in morbidity and mortality, although systemic manifestations such as glomerulonephritis, cerebral vasculitis or pulmonary vasculitis are very rare. Systemic vasculitis with renal involvement is associated with overt polyarthritis in less than 5% and association with rheumatoid arthritis is exceptional. Determination of anti-neutrophil cytoplasmic autoantibodies (ANCA), used in the appropriate clinical context, has become an important diagnostic tool in small-vessel systemic vasculitides. We present two patients with rheumatoid arthritis who subsequently developed systemic vasculitis. ANCA determination was decisive in the early diagnosis of these patients.

Key words:
Rheumatoid arthritis
Vasculitis,
ANCA
Full text is only aviable in PDF
Bibliografía
[1.]
J.C. Jennette, R.J. Falk.
Small-vessel vasculitis.
N Engl J Med, 337 (1997), pp. 1512-1523
[2.]
G.S. Hoffman, G.S. Kerr, R.Y. Leavitt, C.W. Hallahan, R.S. Lebovics, W.D. Travis, et al.
Wegener granulomatosis: an analysis of 158 patients.
Ann Intern Med, 116 (1992), pp. 488-498
[3.]
R.A. DeRemee, H.A. Homburger, U. Specks.
Lesions of the respiratory tract associated with the finding of anti-neutrophil cytoplasmic autoantibodies with a perinuclear staining pattern.
Mayo Clin Proc, 69 (1994), pp. 819-824
[4.]
C.O. Savage, C.G. Winearls, D.J. Evans, A.J. Rees, C.M. Lockwood.
Microscopic polyarteritis: presentation, pathology and prognosis.
Q J Med, 56 (1985), pp. 467-483
[5.]
J.C. Jennette, R.J. Falk, K. Andrassy, P.A. Bacon, J. Churg, W.L. Gross, et al.
Nomenclature of systemic vasculitides. Proposal of an international consensus conference.
Arthritis Rheum, 37 (1994), pp. 187-192
[6.]
L.A. Mandl, D.H. Solomon, E.L. Smith, R.A. Lew, J.N. Katz, R.H. Shmerling.
Using antineutrophil cytoplasmic antibody testing to diagnose vasculitis: can test-ordering guidelines improve diagnostic accuracy?.
Arch Intern Med, 162 (2002), pp. 1509-1514
[7.]
W.H. Schmitt, F.J. Van der Woude.
Clinical applications of antineutrophil cytoplasmic antibody testing.
Curr Opin Rheumatol, 16 (2004), pp. 9-17
[8.]
M. De Bandt, O. Meyer, T. Haim, M.F. Kahn.
Antineutrophil cytoplasmic antibodies in rheumatoid arthritis patients.
Br J Rheumatol, 35 (1996), pp. 38-43
[9.]
T. Messiaen, P. M’Bappe, J.J. Boffa, R. Khayat, B. Mougenot, J. Rossert, et al.
MPO-ANCA necrotizing glomerulonephritis related to rheumatoid arthritis.
Am J Kidney Dis, 32 (1998), pp. E6
[10.]
M.U. Qarni, D.E. Kohan.
Pauci-immune necrotizing glomerulonephritis complicating rheumatoid arthritis.
Clin Nephrol, 54 (2000), pp. 54-58
[11.]
N. Yorioka, Y. Taniguchi, D. Amimoto, H. Miyata, M. Yamakido, T. Taguchi.
Chronic rheumatoid arthritis complicated by myeloperoxidase antineutrophil cytoplasmic antibody-associated nephritis.
Am J Nephrol, 19 (1999), pp. 527-529
[12.]
M. Soubrier, S. Le Seaux, J.J. Dubost, M.H. Mizony, J.M. Ristori, J.L. Bussiere.
Rheumatoid arthritis preceding microscopic polyangitis. Report of two cases.
Rev Med Interne, 21 (2000), pp. 78-82
[13.]
R. Yoshihara, Y. Tanaka, K. Shiozawa, M. Hayakawa, M. Nagao, S. Imura.
Rapidly progressive glomerulonephritis associated with myeloperoxidase specific-antineutrophil cytoplasmic antibody in patients with rheumatoid arthritis: report of three cases.
Ryumachi, 36 (1996), pp. 762-768
[14.]
A. Torralbo, J.A. Herrero, J. Portoles, A. Barrientos.
Alveolar hemorrhage associated with antineutrophil cytoplasmic antibodies in rheumatoid arthritis.
Chest, 105 (1994), pp. 1590-1592
[15.]
G. Douglas, K. Bird, P. Flume, R. Silver, M. Bolster.
Wegener’s granulomatosis in patients with rheumatoid arthritis.
J Rheumatol, 30 (2003), pp. 2064-2069
[16.]
E.J. Borg, F.J. Disch, C.G. Kallenberg.
Erosive polyarthritis as presenting manifestation of Wegener’s granulomatosis.
Clin Rheumatol, 14 (1995), pp. 551-553
[17.]
C.L. Danning, G.G. Illei, D.T. Boumpas.
Vasculitis associated with primary rheumatologic diseases.
Curr Opin Rheumatol, 10 (1998), pp. 58-65
Copyright © 2005. Elsevier España S.L. Barcelona
Download PDF
Idiomas
Reumatología Clínica (English Edition)
Article options
Tools
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?